Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: May 19, 2018
Open Peer Review Period: May 19, 2018 - Jul 14, 2018
Date Accepted: Nov 10, 2018
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Mobile Phone App–Based Pulmonary Rehabilitation for Chemotherapy-Treated Patients With Advanced Lung Cancer: Pilot Study

Park S, Kim JY, Lee JC, Kim HR, Song S, Kwon H, Ji W, Choi CM

Mobile Phone App–Based Pulmonary Rehabilitation for Chemotherapy-Treated Patients With Advanced Lung Cancer: Pilot Study

JMIR Mhealth Uhealth 2019;7(2):e11094

DOI: 10.2196/11094

PMID: 30714943

PMCID: 6378551

Efficacy of smartphone application-based pulmonary rehabilitation in chemotherapy-treated patients with advanced lung cancer: a pilot study

  • Sojung Park; 
  • Ji Youn Kim; 
  • Jae Cheol Lee; 
  • Hyeong Ryul Kim; 
  • Seungjae Song; 
  • Hee Kwon; 
  • Wonjun Ji; 
  • Chang Min Choi

ABSTRACT

Background:

Advanced lung cancer patients often have chronic lung disease with reduced exercise capacities and various symptoms leading to altered quality of life (QoL). No studies have assessed pulmonary rehabilitation (PR) employing a mobile application and an Internet of Things device in advanced lung cancer patients undergoing chemotherapy.

Objective:

We determined the feasibility and efficacy of a smartphone application-based PR on exercise capacity, symptom management, and QoL in these patients.

Methods:

A total of 100 patients were recruited in a prospective, single-arm intervention study using smartphone application-based PR program for 12 weeks. Exercise capacity (6-minute walking distance, 6MWD), QoL, symptom scale scores, and distress indexes were investigated.

Results:

Ninety patients completed the PR program. The most common cause of dropout was hospitalization due to cancer progression. After PR, there was significant improvement in the 6MWD; 380.1 ± 74.1 m at baseline, 429.1 ± 58.6 m at 6-weeks (P < .001), and 448.1 ± 50.0 m at 12-weeks (P < .001). However, the dyspnea scale score showed no significant improvement in the patients overall, but there was a trend for improvement in those with a stable tumor response (P = .065). Role (P = .02), emotional (P < .001), and social functioning (P = .002) scale scores showed significant improvement after PR. Symptom scale scores for fatigue (P < .001), anorexia (P = .047), and diarrhea (P = .01) also showed significant improvement. There was significant improvement in depression (P = .048) and anxiety (P = .01), while there was no significant change in QoL (P = .063) and severity of pain (P = .24).

Conclusions:

Smartphone application-based PR represents an effective and feasible program to improve exercise capacity, and to manage symptoms and distress in patients with advanced lung cancer, undergoing chemotherapy.


 Citation

Please cite as:

Park S, Kim JY, Lee JC, Kim HR, Song S, Kwon H, Ji W, Choi CM

Mobile Phone App–Based Pulmonary Rehabilitation for Chemotherapy-Treated Patients With Advanced Lung Cancer: Pilot Study

JMIR Mhealth Uhealth 2019;7(2):e11094

DOI: 10.2196/11094

PMID: 30714943

PMCID: 6378551

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.